The dose is the signal
Made for people on Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications, it keeps the things that matter most gently on track: protein, hydration, your injections, and how you actually feel
Having an option like semaglutide, which resulted in a mean 16.1% reduction in BMI in adolescents with obesity over 68 weeks in the STEP TEENS trial, should be extremely encouraging to providers who treat adolescents with obesity
With spending projections expecting continued sharp increases, PBMs have an important role to play in shaping prescription patterns more aligned with medical evidence (including trial data, treatment guidelines, medical best practices, etc.) and comparative research rather than drug maker promotional agendas
The results have been excellent I absolutely love it